Sun Pharma Advanced Research Company Q1FY22 loss at Rs. 61.37 Cr
Pharma

Sun Pharma Advanced Research Company Q1FY22 loss at Rs. 61.37 Cr

The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.

  • By ICN Group | July 27, 2021

Sun Pharma Advanced Research Company has reported total income of Rs.22.79 crores during the period ended June 30, 2021 as compared to Rs.28.39 crores during the period ended March 31, 2021.

The company reported total income of Rs.186.11 crores during the period ended June 30, 2020.

Sun Pharma Advanced Research Company has posted net loss of Rs.(61.37) crores for the period ended June 30, 2021 as against net loss of Rs.(56.72) crores for the period ended March 31, 2021.

The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.

Other Related stories

Startup

Chemical

Petrochemical

Digitization

Gas